StandardX raises £10M seed to scale rare isotope production for medicine and fusion
The UK deeptech startup will develop an accelerator-based refinery to produce isotopes used in cancer care and energy, aiming to strengthen Europe's supply of critical rare materials.
AfroEuropa Newsroom
AfroEuropa desk
Deeptech company StandardX has secured £10 million in seed funding to build out its accelerator-based isotope refinery and boost output of rare isotopes used in medicine and energy applications.
The round was led by Vsquared Ventures and East X Ventures, with participation from firstminute capital, UKI2S (the UK Innovation and Science Seed Fund), Brevan Howard Macro Venture and Geometry. Sifted reported the investment as an exclusive.
Founded in 2025 by Richard Pearson, who serves as chief executive, and Ross Allen, the chief technology officer, StandardX was set up by two nuclear engineers with prior experience building startups. The company is developing an isotope refinery designed to manufacture a range of isotopes at commercial scale.
Keep reading
Connect Ventures Reaches $55M First Close of $80M Fund V for European Founders
The early-stage firm's fifth fund is anchored by the British Business Bank and will target technical founding teams across Europe.
Other highlights
Leaked Renders and Specs Point to Samsung Galaxy Tab S12 Plus and Ultra
Leaked marketing materials suggest Samsung's next flagship tablets could arrive on October 7, with details on chips, batteries, and pricing.
Follow the story
One newsletter, two continents
The Bridge brings you the tech, startups, and leaders moving between Africa and Europe in one sharp email each morning. No spam, unsubscribe anytime.
